Could a coronavirus vaccine rehab the pharmaceutical industry's reputation despite drug price increases?

  • 📰 USATODAY
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 63%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

For years, the pharmaceutical industry has faced withering bipartisan criticism and a deteriorating reputation among the public for its role in driving up drug prices.

Pharma industry executives say the vaccine push shows how the industry is committed to using profits, which have been the target of much criticism, to support their pursuit of life-saving medications.

"There are certainly bright spots in the pharma sector in terms of innovation, hope and optimism — and certainly those three things would apply to the work that’s happening around COVID-19," Lash said."But if you look at the performance of Big Pharma and their behavior over the last decade, it paints a very dark picture of drug pricing in America."

Pharmaceutical executives say their pricing is justified due to the high cost of research and development that is now contributing to the pursuit of a vaccine for the coronavirus. He attributed much of the criticism over drug prices to"relatively few bad actors" responsible for sharp increases, including Shkreli, who was later imprisoned after being convicted on unrelated fraud charges, and Mylan.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 100. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Withering bipartisian criticism from elected officials who have taken millions in campaign contributions and enacted no significant legislation in this area. Yeah real withering.....

what a garbage run not taking yoir ahit

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Asian shares waver with coronavirus, corporate earnings in focusAsian stocks dithered on Wednesday as an increase in new coronavirus cases in some parts of the world cast doubts over the economic recovery while oil prices eased on oversupply fears. With the pandemic spiraling out of control in the United States the markets will crash.
La source: Reuters - 🏆 2. / 97 Lire la suite »

Asian shares waver with coronavirus, focus turns to corporate earningsAsian stocks dithered on Wednesday as an increase in coronavirus cases in some parts of the world undermined prospects for a quick economic recovery while oil prices eased on oversupply fears.
La source: Reuters - 🏆 2. / 97 Lire la suite »